Newsletter Archive

1. 10.12.26 -- Choosing The Right CSO For Your 2027 Product Launch 10/12/2026

   10/12/26 Life Science Leader Newsletter

2. 10.10.26 -- Life Science Leader Newsletter - Best Of September 10/10/2026

   10/10/26 Life Science Leader Newsletter

3. 10.09.26 -- Scaling Radiopharma Success: AdvanCell CEO Shares Lessons 10/9/2026

   10/09/26 Life Science Leader Newsletter

4. 10.08.26 -- New Insights On Advancing AAV Development And Beyond 10/8/2026

   10/08/26 Life Science Leader Newsletter

5. 10.05.26 -- FDA Finalizes Psychedelic Drug Guidance: What Sponsors Need To Know 10/5/2026

   10/05/26 Life Science Leader Newsletter

6. 10.02.26 -- Can Virtual Biotechs Thrive Without Institutional Capital? 10/2/2026

   10/02/26 Life Science Leader Newsletter

7. 10.02.26 -- New Podcast Episodes: 2026 Regulatory Updates, Funding A Virtual Biotech, Structuring CGT Deals 10/2/2026
   10/02/26 Life Science Leader Newsletter
8. 09.30.26 -- FDA Engagement Strategies And Best Practices Amid Agency Changes 9/30/2026

   09/30/26 Life Science Leader Newsletter

9. 09.28.26 -- Four Implications Of The Phase 3 Cancer Vaccine Results 9/28/2026

   09/28/26 Life Science Leader Newsletter

10. 09.27.26 -- Can siRNA Therapies Offer Better Results In Obesity? 9/27/2026
    09/27/26 Life Science Leader Newsletter